Avoid the stress of overpaying for a stock or missing an opportunity by using the right tools and insights to evaluate TELA Bio, Inc. before investing.

In this article, we go over a few key elements for understanding TELA Bio, Inc.’s stock price such as:

• TELA Bio, Inc.’s current stock price and volume
• Why TELA Bio, Inc.’s stock price changed recently
• Upgrades and downgrades for TELA from analysts
• TELA’s stock price momentum as measured by its relative strength

About TELA Bio, Inc. (TELA)

Before we jump into TELA Bio, Inc.’s stock price, history, target price and what caused it to recently dip, let’s take a look at some background.

TELA Bio, Inc., a commercial-stage medical technology company, focuses on providing soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient’s anatomy. The company provides a portfolio of OviTex Reinforced Tissue Matrix (OviTex) products for hernia repair and abdominal wall reconstruction; and OviTex PRS Reinforced Tissue Matrix products to address the unmet needs in plastic and reconstructive surgery, as well as OviTex for Laparoscopic and Robotic Procedures, a sterile reinforced tissue matrix derived from ovine rumen with polypropylene, polyglycolic acid, and polylactic-co-glycolic acid designed to be used in laparoscopic and robotic-assisted hernia surgical repairs. It markets its products through a single direct sales force, principally in the United States. TELA Bio, Inc. was incorporated in 2012 and is headquartered in Malvern, Pennsylvania.

Want to learn more about TELA Bio, Inc.’s stock? Click the button below to subscribe to A+ Investor and get access to everything you need to know about TELA Bio, Inc..

TELA Bio, Inc.’s Stock Price as of Market Close

As of October 16, 2026, 4:00 PM, CST, TELA Bio, Inc.’s stock price was $0.975.

TELA Bio, Inc. is down 3.47% from its previous closing price of $1.010.

During the last market session, TELA Bio, Inc.’s stock traded between $0.960 and $1.110. Currently, there are approximately 57.41 million shares outstanding for TELA Bio, Inc..

TELA Bio, Inc.’s trailing earnings per share are negative, so the stock does not have a meaningful P/E ratio. We suggest investors evaluate other financial metrics to understand its overall valuation.

TELA Bio, Inc. Stock Price History

TELA Bio, Inc.’s (TELA) price is currently down 15.22% so far this month.

During the month of October, TELA Bio, Inc.’s stock price has reached a high of $1.300 and a low of $0.960.

Over the last year, TELA Bio, Inc. has hit prices as high as $1.560 and as low as $0.501. Year to date, TELA Bio, Inc.’s stock is down 17.37%.

Sign Up to Receive a Free Special Report Showing How A+ Grades Can Help You Make Smarter Investment Decisions

What Caused TELA Bio, Inc. Stock’s Price to Dip?

Stock prices are primarily based on seller supply and buyer demand. But have you ever wondered about what other factors affect a stock's price?

When an analyst changes their opinion of a stock by upgrading or downgrading their rating, it often leads to a sudden stock price adjustment. As of October 16, 2026, there was 1 analyst who downgraded TELA Bio, Inc.’s stock and 0 analysts who upgraded over the last month.

Additionally, you'll want to evaluate TELA Bio, Inc.’s financial health and valuation. Investors can use AAII's Value Grade, which combines six key valuation metrics like P/E and P/S ratios for a comprehensive analysis to conduct analysis on TELA Bio, Inc.’s valuation and financial health. This approach mitigates the limitations of single-metric evaluations.

Learn how to evaluate stocks with AAII Grades and Scores with A+ Investor today.

Lastly, news and media coverage as well as recent press reports about the company or its industry may cause stock prices to fluctuate. You can check out the most recent news articles about TELA Bio, Inc. (TELA) by visiting AAII Stock Evaluator.

Relative Price Strength of TELA Bio, Inc.

Relative price strength measures a stock's performance against the market, helping investors identify stocks that are outperforming benchmarks.

For AAII’s Momentum Grade, a weighted relative price strength is calculated. Follow this link to learn more about the Momentum Grade.

As of October 16, 2026, TELA Bio, Inc. has a weighted four-quarter relative price strength of 0.33%, which translates to a Momentum Score of 62 and is considered to be Strong.

Want to learn more about how TELA Bio, Inc. is graded based on AAII’s composite scores for value, growth, quality and earnings estimate revisions? Subscribe to A+ Investor today.

TELA Bio, Inc. Stock Price: Bottom Line

As of October 16, 2026, TELA Bio, Inc.’s stock price is $0.975, which is down 3.47% from its previous closing price.

AAII advises against making stock decisions based solely on price or past returns. Instead, consider a variety of metrics, fundamentals, and analytics to evaluate a stock like TELA Bio, Inc. stock prices are influenced by market supply and demand and offer just a snapshot of a company's overall health.

Subscribing to AAII's A+ Investor provides access to comprehensive analytics and insights for confident investing.